D441 Medical Dosage Calculations and Pharmacology - Set 2 - Part 1

Correct Answer: Bedtime dosing maximizes donepezil's absorption since stomach acid is highest during overnight hours

Red Man Syndrome occurs from rapid vancomycin infusion causing histamine release, producing flushing, pruritus, red rash on face and extremities, nausea, and hypotension. Slowing the infusion typically resolves these symptoms. Option b is incorrect because anaphylaxis presents with tachycardia, severe angioedema, bronchospasm, and wheezing requiring epinephrine. These findings are absent in this scenario, which reflects an infusion-rate-related histamine reaction. Option c is incorrect because nephrotoxicity presents as a decline in kidney function evidenced by rising creatinine and reduced urine output, not as flushing, rash, or hypotension occurring during active drug infusion. Option d is incorrect because a true allergic reaction includes angioedema, tachycardia, and wheezing, which are clinically distinct from the infusion-rate-related histamine-mediated symptoms of Red Man Syndrome described here.

Correct Answer: Ototoxicity; stop infusion and notify provider

Tinnitus and hearing difficulty are hallmark signs of vancomycin-induced ototoxicity from inner ear damage. The nurse must stop the infusion and immediately notify the provider to prevent permanent, irreversible hearing loss. Option a is incorrect because Red Man Syndrome involves flushing, rash, pruritus, and hypotension from rapid infusion, not auditory symptoms such as ringing or difficulty hearing during ongoing drug administration. Option b is incorrect because nephrotoxicity presents as declining kidney function with rising BUN and creatinine levels, not auditory symptoms. Ototoxicity and nephrotoxicity are separate adverse effects of vancomycin therapy. Option d is incorrect because an allergic reaction presents with urticaria, angioedema, tachycardia, and breathing difficulty, not hearing loss. Continuing the infusion when ototoxicity is suspected risks causing permanent inner ear damage.

Correct Answer: Nephrotoxicity; hold the dose and notify provider

Vancomycin is associated with nephrotoxicity evidenced by rising creatinine. A significant elevation from baseline indicates potential kidney damage. Holding the dose and notifying the provider prevents further deterioration of renal function. Option a is incorrect because a significantly elevated creatinine is never an expected lab fluctuation during antibiotic therapy. It signals potential organ damage and always requires prompt clinical assessment and an immediate provider response. Option c is incorrect because Red Man Syndrome is a vascular skin reaction caused by histamine release during rapid infusion. It does not cause downstream damage to kidney filtration or produce rising creatinine on laboratory results. Option d is incorrect because ototoxicity affects inner ear structures causing tinnitus and hearing loss. It does not extend to affect kidney function, as the two adverse effects occur through entirely separate physiological mechanisms.

Correct Answer: Normal side effect; monitor for 30 minutes

Localized burning upon IV vancomycin administration is a known and expected normal side effect. The nurse monitors the site for swelling, pain, and redness for 30 minutes without stopping the infusion unless systemic symptoms appear. Option a is incorrect because localized site burning is an expected normal side effect of vancomycin and does not indicate anaphylaxis, which would present with systemic symptoms including wheezing, tachycardia, and angioedema throughout the body. Option b is incorrect because Red Man Syndrome causes diffuse flushing and rash across the face and extremities from rapid infusion, not localized burning and mild swelling confined to the IV insertion site area specifically. Option c is incorrect because IV infiltration produces cool, pale, puffy tissue from fluid leaking outside the vein. This is clinically distinct from the expected localized warmth and burning associated with vancomycin administration.

Correct Answer: Tachycardia, hives, and wheezing confirm allergic reaction

Unlike Red Man Syndrome, a true allergic reaction presents with tachycardia, urticaria, angioedema, and wheezing requiring immediate emergency intervention. These systemic findings distinguish anaphylaxis from infusion-rate-related histamine release. Option b is incorrect because flushing and pruritus alone may suggest Red Man Syndrome, but when tachycardia, hives, and wheezing emerge simultaneously, the clinical picture shifts clearly toward a true systemic allergic reaction. Option c is incorrect because itching localized to the face alone is insufficient to confirm Red Man Syndrome when additional systemic findings including tachycardia and wheezing are also present, indicating a more serious allergic response. Option d is incorrect because nausea combined with flushing is characteristic of Red Man Syndrome. It is specifically the triad of tachycardia, hives, and wheezing, not nausea, that signals a true allergic emergency.

Correct Answer: Non-therapeutic hypertrichosis and fluid retention

Minoxidil's documented non-therapeutic outcomes include hypertrichosis and fluid retention from increased sodium and water retention causing edema and weight gain, which are unwanted effects separate from the intended goal. Option a is incorrect because therapeutic outcomes of minoxidil are limited to blood pressure reduction below 130/80 mmHg and improved renal function. Hair growth and edema represent non-therapeutic side effects, not desired treatment results. Option b is incorrect because hair growth and fluid retention are well-documented pharmacological side effects of minoxidil, not signs of an allergic reaction, which would typically include rash, urticaria, or respiratory symptoms. Option d is incorrect because vancomycin toxicity refers to nephrotoxicity and ototoxicity from vancomycin use. This patient is on minoxidil, and the findings described are specific documented side effects of that medication only.

Correct Answer: Vasodilator; target BP below 130 over 80

Minoxidil is an antihypertensive vasodilator that relaxes blood vessel walls to reduce peripheral resistance. The therapeutic target is blood pressure below 130/80 mmHg, with improved renal function as a secondary benefit. Option b is incorrect because beta-blockers reduce heart rate and cardiac output by blocking adrenaline. Minoxidil does not work through beta-receptor blockade and does not primarily target heart rate to lower blood pressure. Option c is incorrect because diuretics increase urine output to reduce fluid volume. Minoxidil actually causes fluid retention and sodium retention as a non-therapeutic side effect, which is opposite to diuretic pharmacological action. Option d is incorrect because ACE inhibitors block angiotensin I conversion to reduce vasoconstriction. Minoxidil works through direct vasodilation, not through the renin-angiotensin-aldosterone system as ACE inhibitors do.

Correct Answer: Reduces colon ammonia and excretes it through stool

Lactulose is a synthetic sugar that reduces ammonia in the colon by trapping it and triggering osmotic diarrhea that expels ammonia-laden stool. Lower systemic ammonia directly improves cognitive function in hepatic encephalopathy. Option a is incorrect because lactulose does not stimulate liver cell regeneration. It works within the colon to trap and expel ammonia through diarrhea and does not address the underlying hepatic pathology causing elevated ammonia. Option b is incorrect because while lactulose may alter colon pH, its primary mechanism is ammonia reduction through osmotic diarrhea rather than directly suppressing gut bacteria or systemic inflammatory responses. Option c is incorrect because lactulose does not stimulate albumin production. Albumin is synthesized by liver cells, and lactulose works specifically in the colon to reduce ammonia before it reaches systemic circulation.

Correct Answer: Patient is more alert and oriented to person and place

The primary therapeutic goal of lactulose in hepatic encephalopathy is improving cognition by reducing ammonia. Increased alertness and improved orientation directly confirm that ammonia is being successfully expelled from the body. Option a is incorrect because lactulose causes osmotic diarrhea to expel ammonia. While electrolyte shifts may occur, potassium normalization is not a therapeutic marker indicating the drug is achieving its intended cognitive improvement goal. Option c is incorrect because lactulose does not directly act on blood pressure or heart rate. Blood pressure stabilization is not a therapeutic endpoint for lactulose used to treat elevated ammonia levels from hepatic encephalopathy. Option d is incorrect because lactulose does not lower liver enzymes. It works in the colon to expel ammonia. AST and ALT reduction reflects improved liver cell inflammation, which is unrelated to lactulose's pharmacological mechanism.

Correct Answer: Osmotic diarrhea is expected; the drug works this way

Lactulose is a laxative by design. It draws water into the colon causing diarrhea to expel waste and ammonia. Loose, frequent stools are the expected mechanism of action and are not a sign of toxicity or error. Option b is incorrect because loose watery stools are the intended pharmacological action of lactulose, not a sign of overdose. Reducing the dose without provider guidance may prevent the drug from reaching its full therapeutic goal. Option c is incorrect because holding lactulose when it is producing expected diarrhea eliminates its therapeutic benefit entirely. The diarrhea is the specific mechanism through which ammonia is expelled safely from the body. Option d is incorrect because frequent loose stools are the expected and documented therapeutic action of lactulose. Notifying the provider is unnecessary unless the patient develops signs of dehydration or severe electrolyte imbalance.

Correct Answer: Tardive dyskinesia from long-term antipsychotic use

Tardive dyskinesia is characterized by involuntary facial movements including lip smacking, tongue thrusting, and blinking caused by long-term dopamine-blocking antipsychotic medications. The nurse reports findings and prepares for gradual medication tapering. Option a is incorrect because acute dystonia involves sudden sustained muscle contractions such as torticollis or oculogyric crisis, not the repetitive, slow, involuntary facial movements characteristic of long-term antipsychotic-induced tardive dyskinesia. Option b is incorrect because Parkinson's disease involves tremors, rigidity, and bradykinesia from low dopamine, not involuntary repetitive facial movements arising from long-term antipsychotic dopamine receptor blockade. Option c is incorrect because neuroleptic malignant syndrome is a life-threatening emergency presenting with hyperthermia, severe muscle rigidity, altered consciousness, and autonomic instability, none of which are present in this description.

Correct Answer: Gradual tapering prevents worsening symptoms and rebound

Antipsychotic medications must be tapered gradually to avoid worsening tardive dyskinesia symptoms or triggering psychiatric rebound. Abrupt discontinuation can cause sudden deterioration in both movement disorder control and psychiatric stability. Option a is incorrect because abrupt antipsychotic cessation is not primarily associated with hypertensive crisis or seizures. The main risks are worsening movement disorder symptoms and psychiatric relapse from sudden dopamine receptor changes. Option c is incorrect because drug half-life and elimination are not affected by whether a medication is tapered or stopped abruptly. Tapering is done for therapeutic symptom management reasons, not to alter pharmacokinetic drug clearance. Option d is incorrect because Red Man Syndrome is an adverse effect of rapid vancomycin IV infusion involving histamine release. It is completely unrelated to antipsychotic discontinuation or the management of tardive dyskinesia.

Correct Answer: Take on empty stomach before meals and medications

Sucralfate works by adhering directly to ulcers when the stomach is empty. It must be taken one to two hours before meals or other medications to bind to the ulcer surface before food or drugs are introduced. Option b is incorrect because taking sucralfate with food prevents the drug from adhering directly to the ulcer. An empty stomach is required for the medication to properly coat and protect the damaged mucosal surface effectively. Option c is incorrect because taking sucralfate immediately after eating means the stomach is full, reducing the drug's ability to properly coat the ulcer. Food competition prevents direct binding to the damaged mucosal tissue. Option d is incorrect because while sucralfate is given at bedtime, limiting it to bedtime only is insufficient. The standard dosing requires four times daily on an empty stomach to maintain continuous throughout-the-day ulcer protection.

Correct Answer: Four times daily on empty stomach

Sucralfate is prescribed four times daily on an empty stomach. This frequency maintains a consistent protective coating over the ulcer throughout the day, including at bedtime, ensuring optimal mucosal healing and acid barrier protection. Option a is incorrect because once-daily dosing is insufficient to maintain continuous mucosal protection. Sucralfate requires four times daily administration to sustain a consistent protective barrier over the ulcer surface throughout the day. Option b is incorrect because taking sucralfate with meals reduces its effectiveness by preventing direct adherence to the ulcer. Sucralfate is not an antacid and does not function to neutralize stomach acid during food digestion. Option c is incorrect because three times daily does not match the standard sucralfate prescription of four times daily. Underdosing reduces the frequency of mucosal coating and significantly diminishes the drug's overall therapeutic protective effect.

Correct Answer: Anticholinergic managing postoperative nausea and vomiting

Scopolamine is an anticholinergic medication prescribed to treat and manage postoperative nausea and vomiting by blocking muscarinic cholinergic receptors involved in triggering the nausea and vomiting neural response. Option a is incorrect because opioids relieve pain and can actually cause nausea as a documented side effect. Scopolamine is not an opioid and does not work by blocking pain signals that trigger nausea centrally or peripherally. Option b is incorrect because serotonin antagonists such as ondansetron block 5-HT3 receptors to reduce nausea. Scopolamine works through anticholinergic muscarinic receptor blockade, not through serotonin receptor antagonism mechanisms. Option d is incorrect because dopamine agonists stimulate dopamine receptors and are used for conditions like Parkinson's disease. Scopolamine does not act on dopamine receptors or enhance gastric emptying to manage postoperative nausea.

Correct Answer: Digoxin toxicity; hold dose and notify provider

Classic signs of digoxin toxicity include visual disturbances such as halos and blurred vision, nausea, loss of appetite, and confusion. The nurse must hold the dose, assess electrolytes, and notify the provider for urgent management. Option a is incorrect because seeing halos around lights, anorexia, and nausea are toxic signs of digoxin accumulation, not therapeutic effects. Therapeutic digoxin maintains cardiac function without producing visual disturbances or GI toxicity symptoms. Option c is incorrect because digoxin toxicity mimics GI illness and visual disturbances caused by drug accumulation, not immune-mediated allergy. Antihistamines do not treat digoxin toxicity and would not address the underlying pharmacological cause. Option d is incorrect because the combination of visual changes, anorexia, and nausea in a patient on digoxin is a textbook toxicity presentation. The nurse cannot dismiss these findings without first ruling out digoxin accumulation.

Correct Answer: Digoxin toxicity from low potassium and magnesium

Hypokalemia and hypomagnesemia both increase digoxin's effect on cardiac cells, raising toxicity risk even at therapeutic drug levels. Monitoring and correcting electrolytes is a critical nursing responsibility for all patients on digoxin therapy. Option a is incorrect because digoxin does not cause potassium accumulation or hyperkalemia. Hypokalemia, not hyperkalemia, is the specific electrolyte imbalance that increases digoxin toxicity risk by sensitizing cardiac tissue. Option b is incorrect because digoxin acts primarily on the heart and does not cause significant respiratory depression. Respiratory depression is most commonly associated with opioid and benzodiazepine drug classes, not cardiac glycosides. Option c is incorrect because rhabdomyolysis involves skeletal muscle breakdown and is primarily associated with statin medications and severe hyperthermia, not digoxin therapy or electrolyte abnormalities of potassium and magnesium.

Correct Answer: Hold digoxin and notify the provider now

Digoxin must be held if the apical pulse is below 60 beats per minute before administration. A rate of 54 is below this established threshold. The nurse holds the dose and notifies the provider for further orders and assessment. Option a is incorrect because administering digoxin when the apical pulse is below 60 beats per minute violates established safety parameters. Digoxin further slows heart rate and can cause life-threatening bradycardia if given at this rate. Option b is incorrect because rechecking the pulse after giving the dose does not address the unsafe heart rate before administration. Digoxin must be withheld when the apical pulse is below 60 beats per minute before giving it. Option d is incorrect because nurses do not independently reduce prescribed medication doses without a provider order. The prescribed dose is held entirely and the provider is notified to determine next steps and any dose adjustment.

Correct Answer: Voiding over 30 mL hourly with non-distended bladder

Bethanechol is a cholinergic agent that stimulates bladder muscle contraction to promote emptying. The expected therapeutic outcome is successful voiding with urine output exceeding 30 mL/hr and a soft, non-distended bladder on assessment. Option b is incorrect because bethanechol stimulates detrusor muscle contraction to facilitate complete bladder emptying. Reducing urgency is not the therapeutic endpoint; active voiding with adequate output and bladder decompression is the target. Option c is incorrect because bethanechol acts on bladder smooth muscle through cholinergic stimulation and does not directly regulate blood pressure. Blood pressure normalization is not a therapeutic outcome associated with this medication. Option d is incorrect because return of bowel sounds indicates GI motility recovery, not bladder function restoration. While bethanechol may stimulate GI smooth muscle secondarily, the primary therapeutic endpoint is successful bladder emptying.

Correct Answer: Intramuscular or subcutaneous injection into muscle

For an unconscious patient unable to take oral medications, glucagon from the emergency kit is administered intramuscularly or subcutaneously to rapidly raise blood glucose. This route is safe and effective in the home setting. Option a is incorrect because an unconscious or unresponsive patient cannot safely receive sublingual medications. There is no sublingual tablet form of glucagon, and this route poses a serious aspiration risk in unresponsive patients. Option c is incorrect because IV glucagon requires clinical expertise and established intravenous access. Emergency glucagon kits are specifically designed for IM or SUBQ administration outside the hospital by untrained family members. Option d is incorrect because oral administration of any medication to an unconscious patient creates a life-threatening aspiration risk. Glucagon emergency kits are explicitly designed for injection, not oral administration under any circumstances.